Ask yourself, what would be NWBO’s market cap if all the many shares the company has printed were suddenly $20. Do you think any company is going to pay that much especially when approval has not happened yet and we’re only talking TLD and a TLD that like a true NWBO product will be ambiguous and debatable and probably only prove strong efficacy in some subgroups and will have confounding from the crossover patients.
We might get a buyout and one that makes us whole or at least as whole as we’re going to get.
But saying $20 today is like the folks who used to say $100 a share back in 2015.
Believe me, I would be THRILLED to be wrong as getting $20 a share after years of misery would be a decent reward.
News 
Market Data 
Discover 
AI
